Winning Health(300253)2025-04-18 14:30Financial Performance - In 2024, the company's operating revenue decreased by 12.05% year-on-year, while the net profit attributable to shareholders dropped by 75.45%[4] - The decline in performance was primarily due to deferred customer demand, delays in bidding processes, and the ongoing upgrade of the new generation product WiNEX, which has not yet converted into significant revenue[4] - The company's operating revenue for 2024 was ¥2,782,240,900.17, a decrease of 12.05% compared to ¥3,163,424,802.81 in 2023[18] - The net profit attributable to shareholders for 2024 was ¥87,893,175.35, down 75.45% from ¥357,959,124.85 in 2023[18] - The company reported a basic earnings per share of ¥0.0408 for 2024, a decline of 75.52% from ¥0.1667 in 2023[18] - The company experienced a significant decline in net profit after deducting non-recurring gains and losses, with a figure of ¥124,179,786.57 in 2024, down 62.66% from ¥332,572,205.54 in 2023[18] - The weighted average return on equity decreased to 1.53% in 2024 from 6.65% in 2023, indicating a decline in profitability[18] - The company reported a net loss in the fourth quarter of 2024, with a net profit attributable to shareholders of -¥66,737,631.33[20] Cash Flow and Investments - The cash flow from operating activities increased by 120.53% to ¥407,530,345.26 in 2024, compared to ¥184,799,838.70 in 2023[18] - The company's total sales, management, and R&D expenses decreased by 17.94% year-on-year, while net cash flow from operating activities increased by 120.53%[55] - The company reported a significant investment loss of ¥48,245,970.27, which accounted for -55.48% of total profit[88] - Investment activity cash inflow decreased by 90.05% to ¥8,952,261.62 in 2024 from ¥90,013,021.46 in 2023[86] - The total investments during the reporting period were ¥10,018,000.00, a significant decrease of 93.63% compared to ¥157,156,300.00 in the same period last year[93] Market and Industry Trends - The software and information technology services industry, in which the company operates, is strongly supported by national policies, with no signs of overcapacity or continuous decline[4] - The software industry in China is projected to grow, with software business revenue expected to reach ¥14 trillion by 2025, averaging over 12% annual growth[28] - The hospital application software market is forecasted to maintain a compound annual growth rate (CAGR) of 11.0% from 2023 to 2028, reaching a total market size of ¥26.58 billion by 2028[29] - The AI electronic medical record system market is projected to grow from 31.2 billion by 2032, with a compound annual growth rate (CAGR) of approximately 15.9% from 2025 to 2032[30] Risk Management - The company acknowledges potential risks including technology and product development risks, talent loss risks, industry competition risks, and management risks[5] - The company emphasizes that forward-looking statements regarding future plans and strategies do not constitute profit forecasts or commitments to investors[5] - Increased industry competition poses a risk, necessitating proactive management measures and increased R&D investment to maintain competitive advantages[113] - Talent retention is critical, as the software industry faces high turnover rates, and the loss of key personnel could impact the company's innovation and competitiveness[113] Research and Development - R&D investment reached 562 million yuan, accounting for 20.21% of operating revenue, with 98 new patents obtained during the reporting period[58] - The company is currently developing five major R&D projects aimed at enhancing its product line and market competitiveness[80] - The company has obtained over 1,500 software copyright certificates, reflecting its commitment to R&D and technological innovation[53] - The company deployed AI applications and large models for over 20 users by the end of 2024, with an additional 80 users added in the first quarter of 2025[59] Governance and Compliance - The financial report has been verified by the board of directors and senior management, ensuring its accuracy and completeness[4] - The company adheres to strict governance practices, ensuring compliance with relevant laws and regulations, and maintaining a robust governance structure[124] - The company has established specialized committees under the board to improve governance and operational oversight[124] - The company is committed to providing equal treatment to all shareholders during meetings, ensuring their rights are upheld[124] Shareholder Returns - The company has proposed a profit distribution plan, offering a cash dividend of 0.15 yuan per 10 shares (tax included) to all shareholders[6] - The company implemented a cash dividend of ¥42.92 million and repurchased shares worth ¥79.99 million to enhance shareholder returns[64] - The company approved a cash dividend of RMB 0.20 per 10 shares (including tax) for the 2023 profit distribution plan, with a total cash dividend amounting to RMB 32,963,566.41[162] - The total cash dividend, including other methods such as share repurchase, reached RMB 112,953,561.93, representing 100% of the profit distribution total[164] Employee Management - The total number of employees at the end of the reporting period is 5,679, with 3,327 in the parent company and 2,352 in major subsidiaries[156] - Employee compensation accounted for 50,352.10 million yuan, representing 31.03% of the company's operating costs for the current period[158] - The company has established a comprehensive training system, including the WiN Academy, which offers various training programs to enhance employee skills and cultural identity[159] - The company has implemented a performance-based compensation system to ensure internal equity and external competitiveness in employee salaries[158] Strategic Initiatives - The company continues to focus on maintaining its core competencies and exploring market expansion opportunities[4] - The company is actively expanding its market presence through localized services and centralized management, enhancing customer engagement and service efficiency[53] - The company plans to expand its market presence with new product launches and technological innovations, targeting a 66% increase in operational efficiency by the end of 2024[100] - The company aims to enhance its digital management capabilities, with a focus on supply chain optimization and resource allocation[101]